APA (7th ed.) Citation

JJ, R., J, H., ME, M., & GM, C. (2024). Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild/moderate chronic kidney disease. Diabetes, obesity & metabolism, 26(4), 1273. https://doi.org/10.1111/dom.15427

Chicago Style (17th ed.) Citation

JJ, Rhee, Han J, Montez-Rath ME, and Chertow GM. "Comparative Effectiveness of Sodium-glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Mild/moderate Chronic Kidney Disease." Diabetes, Obesity & Metabolism 26, no. 4 (2024): 1273. https://doi.org/10.1111/dom.15427.

MLA (9th ed.) Citation

JJ, Rhee, et al. "Comparative Effectiveness of Sodium-glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes and Mild/moderate Chronic Kidney Disease." Diabetes, Obesity & Metabolism, vol. 26, no. 4, 2024, p. 1273, https://doi.org/10.1111/dom.15427.